Scientists Slam Chinese CRISPR Babies Research After Manuscript Released

Chinese biophysicist He Jiankui had created the twins Lula and Nana in late 2018 using CRISPR.

Advertisement
By Agence France-Presse | Updated: 4 December 2019 10:26 IST
Highlights
  • Gene-editing was performed on Chinese twins last year
  • It was meant to immunise them against HIV
  • It may have failed in its purpose and created unintended mutations

Chinese scientist He Jiankui in a summit on Human Genome Editing in November 2018

Photo Credit: Anthony Wallace/ AFP

The gene-editing performed on Chinese twins last year meant to immunise them against HIV may have failed in its purpose and created unintended mutations, scientists said Tuesday after the original research was made public for the first time. Excerpts from the manuscript were released by the MIT Technology Review for the purpose of showing how Chinese biophysicist He Jiankui ignored ethical and scientific norms in creating the twins Lula and Nana, whose birth in late 2018 sent shockwaves through the scientific world.

He made expansive claims of a medical breakthrough that could "control the HIV epidemic," but it was not clear whether it had even been successful in its intended purpose -- immunizing the babies against the virus -- because the team did not, in fact, reproduce the gene mutation that confers this resistance.

Advertisement

A small percentage of people are born with immunity because of a mutation in a gene called CCR5 and it was this gene that He had claimed he had targeted using a powerful editing tool known as CRISPR which has revolutionized the field since bursting on the scene in 2012.

Fyodor Urnov, a genome-editing scientist at the University of California, Berkeley told the MIT Technology Review: "The claim they have reproduced the prevalent CCR5 variant is a blatant misrepresentation of the actual data and can only be described by one term: a deliberate falsehood.

"The study shows that the research team instead failed to reproduce the prevalent CCR5 variant."

While the team targeted the right gene, they did not replicate the "Delta 32" variation required, instead creating novel edits whose effects aren't clear.

Advertisement

Moreover, CRISPR remains an imperfect tool because it can lead to unwanted or "off-target" edits, making its use in humans hugely controversial.

Here, the researchers claimed they had searched for such effects in the early-stage embryos and found just one -- but this glossed over the fact that it would be impossible to carry out a comprehensive search without inspecting each of the embryo's cells and thus destroying it.

Advertisement

Further ethical concerns included that the parents of the babies might have wanted to take part for the wrong reasons.

The father was HIV positive, which carries a significant social stigma in China and makes it almost impossible to have access to fertility treatment, even though a well-established technique known as "sperm washing" prevents the infection from being passed on to unborn children.

Advertisement

Their lack of access to any kind of fertility treatment may have motivated them to take part in the experiment despite the huge risks to their children, Jeanne O'Brien, a reproductive endocrinologist at Shady Grove Fertility told the MIT Technology Review.

The authors also appeared to have taken steps to make it hard to find the family, like leaving the names of the fertility doctors off the paper, and including a false date of birth (Hu claimed November 2018 while multiple reports have indicated it was in fact October 2018).

He attempted to shop his manuscript around to prestigious journals including Nature and JAMA, but it remains unpublished.

 

Get your daily dose of tech news, reviews, and insights, in under 80 characters on Gadgets 360 Turbo. Connect with fellow tech lovers on our Forum. Follow us on X, Facebook, WhatsApp, Threads and Google News for instant updates. Catch all the action on our YouTube channel.

Further reading: CRISPR, Gene-editing
Advertisement

Related Stories

Popular Mobile Brands
  1. iQOO Neo 12 With a 9,000mAh Battery Debuts at This Price
  2. MacBook Pro With PROLED XDR Touchscreen Debuts in India at This Price
  3. Vivo X500, X500 Pro, X500 Pro Max Launched Globally
  4. Redmi Book 2027 Series With Up to Intel Core 7 Processor Debuts: See Price
  5. Moto G47 Power Debuts With 120Hz Display, Dimensity 6300 Chipset
  6. OnePlus Ace 7 Chipset, Battery, Charging Details Teased Ahead of Launch
  7. OnePlus Ace 7 Teased to Get Tri-Cluster Chip Setup Ahead of Launch
  8. Lava Diwali Sale Offers Announced on Smartphones and Feature Phones in India
  1. MacBook Pro With PROLED XDR Display Launched in India as Apple’s First Touchscreen Laptop: Price, Specifications
  2. Lava Diwali Sale Offers Announced on Smartphones and Feature Phones in India
  3. Coinbase, Bithumb and South Korean Financial Firms Report Data Leaks
  4. Third-Party Android App Stores Can Now Enrol in Google's Registered App Stores Programme
  5. Ai+ Smartphone Prices Hiked by Up to Rs 3,000 in India From November 15: Check New Prices
  6. Avalanche Allows Tokenised Treasury Holdings to Secure Loans and Trades
  7. iQOO Pad Pro 8.8 Launched With 165Hz AMOLED Display, Snapdragon 8 Elite Gen 5 Chip: Price, Specifications
  8. iQOO Neo 12 Launched With 9,000mAh Battery, 185Hz Super AMOLED Display: Price, Specifications
  9. Samsung Galaxy Z Fold 9 Plus or Galaxy Z Fold 9 FE Could Launch in 2027
  10. Samsung W27 Leaked Renders Show Foldable Phone From Multiple Angles Ahead of Launch
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2026. All rights reserved.